Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04042857 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Next Science Gel on Toenail Fungus
A NA study of Onychomycosis of Toenail, sponsored by Next Science TM.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04042857: Recruiting NA study of Onychomycosis of Toenail, sponsored by Next Science TM.
NCT04042857 is a NA study of Onychomycosis of Toenail that is actively recruiting participants, run by Next Science TM. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04042857, a NA study of Onychomycosis of Toenail, is actively recruiting participants, sponsored by Next Science TM.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 52 week, 20-patient open-label pilot study on the safety and efficacy of Next Science Wound gel in the treatment of mild to moderate Distal Subungual Onychomycosis.
Primary Outcome
Mycological cure rate at week 48 as defined by negative potassium hydroxide examination and negative culture of the target hallux nail
Conditions Studied
Interventions
- DEVICE Next Science Treatment Gel
Study Locations (1)
Florida
- Doctors Research Network - South Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-26 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
What NCT04042857 shows while recruiting
NCT04042857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Onychomycosis of Toenail appearing as the primary indexed condition, and to 1 intervention - of which Next Science Treatment Gel is the first listed.
NCT04042857 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04042857 about?
NCT04042857 is a clinical study titled "Safety and Efficacy of Next Science Gel on Toenail Fungus". This is a 52 week, 20-patient open-label pilot study on the safety and efficacy of Next Science Wound gel in the treatment of mild to moderate Distal Subungual Onychomycosis.
What is the current status of trial NCT04042857?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2019-07-26. Estimated completion is 2021-10-01.
What conditions does trial NCT04042857 study?
This clinical trial studies the following conditions: Onychomycosis of Toenail.
What interventions are being tested in trial NCT04042857?
The interventions under investigation include: Next Science Treatment Gel (DEVICE).
Who is sponsoring clinical trial NCT04042857?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04042857 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis of Toenail
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04042857's enrollment target sits among peer trials
20 1769th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI